|Other Names||BPI fold-containing family B member 2, Bactericidal/permeability-increasing protein-like 1, BPI-like 1, Long palate, lung and nasal epithelium carcinoma-associated protein 2, RYSR, BPIFB2, BPIL1, C20orf184, LPLUNC2|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP7427a was selected from the N-term region of human BPIL1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Synonyms||BPIL1, C20orf184, LPLUNC2|
|Tissue Location||Highly expressed in tonsils, especially in hypertrophic tonsils. Detected at very low levels in fetal liver|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
BPIL1 is a member of the lipid transfer/lipopolysaccharide binding protein (LT/LBP) family. This protein is highly expressed in hypertrophic tonsils.
Clark H.F., Gurney A.L., Abaya E.Genome Res. 13:2265-2270(2003)Deloukas P., Matthews L.H.Nature 414:865-871(2001)Mulero J.J., Boyle B.J., Bradley S.Immunogenetics 54:293-300(2002)
If you have any additional inquiries please email technical services at firstname.lastname@example.org.